Envoy Medical (Envoy Medical) EBIT per Share : $-1.06 (TTM As of Mar. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Envoy Medical EBIT per Share?

Envoy Medical's EBIT per Share for the three months ended in Mar. 2024 was $-0.32. Its EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 was $-1.06.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the EBIT per Share growth rate using EBIT per Share data.

The historical rank and industry rank for Envoy Medical's EBIT per Share or its related term are showing as below:

COCH's 3-Year EBIT Growth Rate is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 5.65
* Ranked among companies with meaningful 3-Year EBIT Growth Rate only.

Envoy Medical's EBIT for the three months ended in Mar. 2024 was $-6.23 Mil.

Envoy Medical EBIT per Share Historical Data

The historical data trend for Envoy Medical's EBIT per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Envoy Medical EBIT per Share Chart

Envoy Medical Annual Data

Trend

Dec21

Dec22

Dec23

EBIT per Share

-0.68

-0.86

-1.46

Envoy Medical Quarterly Data
	Dec21	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
EBIT per Share	Get a 7-Day Free Trial				-1.18	-0.23	-0.17	-0.34	-0.32

Envoy Medical EBIT per Share Calculation

EBIT per Share is the amount of Earnings Before Interest and Taxes (EBIT) per outstanding share of the company's stock.

Earnings Before Interest and Taxes (EBIT) is what the company earns before it expenses interest and taxes.

Envoy Medical's EBIT per Share for the fiscal year that ended in Dec. 2023 is calculated as

	EBIT per Share		(A: Dec. 2023 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-18.371	/	12.553
=	-1.46

Envoy Medical's EBIT per Share for the quarter that ended in Mar. 2024 is calculated as

	EBIT per Share		(Q: Mar. 2024 )
=	EBIT	/	Shares Outstanding (Diluted Average)
=	-6.234	/	19.600
=	-0.32

EBIT per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-1.06

Envoy Medical (NAS:COCH) EBIT per Share Explanation

EBIT is a company's earnings before interest and tax expenses are deducted. It measures a company's profit generates from operating, ignoring tax burden and capital structure. As the tax expense are not deducted, EBIT is helpful when comparing companies in the same industry but with different tax situations. Also, the interest expense are included in EBIT, making it useful to compare companies that have high interest expenses due to large amount of debt.

Envoy Medical EBIT per Share Related Terms

Thank you for viewing the detailed overview of Envoy Medical's EBIT per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Envoy Medical (Envoy Medical) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Envoy Medical Inc (NAS:COCH) » Definitions » EBIT per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

4875 White Bear Parkway, White Bear Lake, MN, USA, 55110

Website

https://www.envoymedical.com

Envoy Medical Inc is focused on designing, developing, and marketing fully implantable medical devices that improve hearing. The Company's first commercial product, the Esteem PMA application, is a fully implantable hearing device. The Esteem PMA was cleared in 2010 by the United States Food and Drug Administration. The Company intends to continue to pursue the development of a cochlear implant.